about
Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinomaIntegration of genome scale data for identifying new players in colorectal cancerAnalysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAsComparative mapping of the actin-binding protein 280 genes in human and mouseFunctional annotation of a full-length mouse cDNA collectionNqA: an R-based algorithm for the normalization and analysis of microRNA quantitative real-time polymerase chain reaction data.MIF/CD74 axis is a target for novel therapies in colon carcinomatosis.Limits of predictive models using microarray data for breast cancer clinical treatment outcome.Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation.Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells.Effects of warm ischemic time on gene expression profiling in colorectal cancer tissues and normal mucosaDPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan.Molecular predictors of response and outcome in ovarian cancer.Misbehaviour of XIST RNA in breast cancer cells.Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesisGene discovery in genetically labeled single dopaminergic neurons of the retinamiR-342 regulates BRCA1 expression through modulation of ID4 in breast cancer.A methodological procedure for evaluating the impact of hemolysis on circulating microRNAs.Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancerCombined analysis of chromosomal instabilities and gene expression for colon cancer progression inference.Role of cMET in the development and progression of colorectal cancerChallenges in projecting clustering results across gene expression-profiling datasets.Transcriptional network dynamics in macrophage activation.Gold-nanoparticle-based colorimetric discrimination of cancer-related point mutations with picomolar sensitivity.Gene expression profile identifies a rare epithelioid variant case of pleomorphic liposarcoma carrying FUS-CHOP transcript.The Effects of miR-20a on p21: Two Mechanisms Blocking Growth Arrest in TGF-β-Responsive Colon Carcinoma.miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation.To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy.Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer.Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.M-CAM expression as marker of poor prognosis in epithelial ovarian cancer.Regulation of lipocalin-2 gene by the cancer chemopreventive retinoid 4-HPR.Specific gene expression profiles distinguish among functional allelic variants of the mouse Pthlh gene in transfected human cancer cells.Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2.Genetics of liver tumor susceptibility in mice.Comment on 'Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'-Methodological challenges in combining miRNAs as circulating biomarkersAllele-specific patterns of the mouse parathyroid hormone-related protein: influences on cell adhesion and migration.CTAB-urea method purifies RNA from melanin for cDNA microarray analysis.Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer.
P50
Q24309898-474FD820-0170-4B71-AF4D-AF7B206AFEFCQ26774701-674C09E5-82EF-4CA6-AE6A-C1FA96CD119EQ28131821-9A6BC990-9A90-4369-8E64-E1C235203213Q28248382-CEC9F194-882F-4FA9-B00D-AF20A06AE3D9Q29618568-D2F300EC-C986-4BB5-A812-DD9C531C708FQ30828643-23F22F46-328C-4BBC-9D34-3B2BAB1A74F7Q30836134-3EE2EE4D-EF91-415B-AFA9-01EDF823BDC4Q30992101-37381B22-EA18-4B33-AF75-DF0216998F97Q33412380-AF700631-4AE2-4168-89EA-80DC72101153Q34078370-FA82BF33-6F67-4915-9B37-A4FAE9D73DC2Q34091302-4CB0ABFB-0402-4874-8B0D-5FB56638E29EQ34545033-301462D5-C43D-40D2-AFA2-860F743385C8Q36072520-F633CC0F-345C-4835-A696-8B8E9E46BBECQ36531089-F0D944DF-3B46-4782-BE2A-FF58FD33DFDDQ37184717-9B93917B-D24F-4C6C-8F19-5E9731A45B51Q37401543-12A210D8-61EA-48DD-8CC7-550BEA6C2387Q37416168-9AB1E299-5130-47CC-8113-95E3E28C03BBQ37521015-EB2A4B0F-4888-4BB7-9BB8-DC69FEB383A1Q37593931-E4717303-71CD-414D-BFE4-13565FCF3E8FQ37594418-E2E96738-4484-427F-8136-0BA664BBDAB3Q37597565-6C957B5A-91C7-49F4-AF61-6DFFA5CF70CBQ38134309-699212EC-22B0-4B2C-A580-6BAB8FEA4BE1Q38296482-CF9382BC-2F1D-4C26-B85F-B5D0E9E041E4Q38313362-6F956534-315D-4326-960A-86A257502A61Q38315299-7C312E9F-8E8A-4999-97F8-FF326F206C8BQ38330439-4FCC918E-E2DF-44A9-9B42-238667F6A20BQ38870781-BCFBCA94-DCBD-4B0C-B35A-3F65E958B38FQ39394993-E8537767-2CE9-4D56-8930-F89AABD09ABEQ39884923-3B169C69-C1D8-486B-9CB5-F4CAEA775D01Q39977561-1458D96D-98F8-4215-B072-B9672D43B0CEQ40184776-FC1CC236-4218-4001-A968-2BAB3C8AC088Q40262325-0F7460BA-009D-4887-97F0-259CC9C26995Q40284270-11F60B9E-B1E3-4F4D-9B33-0BA6499996BEQ40302230-24C314E6-E908-4A24-A636-FAC8B9B0A7CDQ40514008-247FA887-074F-42E9-AC71-FE29E1B2270AQ40967225-EEC3A988-8611-4959-B797-E7E62AF5FECFQ41512938-B4BD6D4E-38FC-47E5-A04A-870515315163Q42834555-798EE004-7378-4413-8BA9-F6E1A53F2185Q44893865-29BC54AA-2632-4168-97BD-237E0EEABFDEQ45333964-20A1592D-A8DB-493C-9DCE-AC8C10B0F1B7
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Manuela Gariboldi
@ast
Manuela Gariboldi
@en
Manuela Gariboldi
@es
Manuela Gariboldi
@nl
Manuela Gariboldi
@sl
type
label
Manuela Gariboldi
@ast
Manuela Gariboldi
@en
Manuela Gariboldi
@es
Manuela Gariboldi
@nl
Manuela Gariboldi
@sl
prefLabel
Manuela Gariboldi
@ast
Manuela Gariboldi
@en
Manuela Gariboldi
@es
Manuela Gariboldi
@nl
Manuela Gariboldi
@sl
P1053
K-4744-2016
P106
P1153
7003940110
P21
P31
P3829
P496
0000-0001-8406-165X